Literature DB >> 7792796

Aldosterone biosynthesis and action in vascular cells.

R Takeda1, H Hatakeyama, Y Takeda, K Iki, I Miyamori, W P Sheng, H Yamamoto, I A Blair.   

Abstract

In view of the hypothetical possibility that the vascular renin-angiotensin system (RAS) might include aldosterone biosynthesis and action in the vasculature, we have undertaken a study to identify aldosterone released into the perfusion circuit from the rat mesenteric artery, and to investigate the effects of an angiotensin converting enzyme inhibition (ACEI) on aldosterone production from the vasculature. After 30 min equilibration, 240 mL of perfusate was collected and subjected to reverse-phase HPLC and subsequent mass spectrometry. Mass spectra corresponding to authentic corticosterone and aldosterone were obtained from the samples of mesenteric artery perfusate. Production of aldosterone in the mesenteric artery was not changed by adrenalectomy, although it was reduced in the arterial perfusate from rats pretreated with ACEI. By RT-PCR the expression of CYP 11B2 and mineralocorticoid receptor genes were demonstrated in both vascular endothelial and smooth muscle cells. These studies constitute indirect evidence supporting our hypothesis that locally produced aldosterone in the vascular tissue acts on vascular tone and remodeling via a paracrine or autocrine manner.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7792796     DOI: 10.1016/0039-128x(94)00026-9

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  17 in total

Review 1.  Aldosterone and vascular damage.

Authors:  D Duprez; M De Buyzere; E R Rietzschel; D L Clement
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

2.  The effect of intrafetal infusion of metyrapone on arterial blood pressure and on the arterial blood pressure response to angiotensin II in the sheep fetus during late gestation.

Authors:  K E Warnes; C L Coulter; J S Robinson; I C McMillen
Journal:  J Physiol       Date:  2003-10-15       Impact factor: 5.182

Review 3.  Mineralocorticoid receptors in vascular function and disease.

Authors:  Amy McCurley; Iris Z Jaffe
Journal:  Mol Cell Endocrinol       Date:  2011-06-24       Impact factor: 4.102

Review 4.  How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension.

Authors:  Mordecai P Blaustein; Frans H H Leenen; Ling Chen; Vera A Golovina; John M Hamlyn; Thomas L Pallone; James W Van Huysse; Jin Zhang; W Gil Wier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

5.  Feedforward activation of endothelial ENaC by high sodium.

Authors:  Stefanie Korte; Alexandra S Sträter; Verena Drüppel; Hans Oberleithner; Pia Jeggle; Claudia Grossmann; Manfred Fobker; Jerzy-Roch Nofer; Eva Brand; Kristina Kusche-Vihrog
Journal:  FASEB J       Date:  2014-05-27       Impact factor: 5.191

6.  Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.

Authors:  Lisa A Cassis; Marc J Helton; Deborah A Howatt; Victoria L King; Alan Daugherty
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

7.  Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone.

Authors:  J C Xiu; P Wu; J P Xu; Z Guo; W Lai; Y Zhang; S Li; J Li; Y Liu
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

Review 8.  This is not Dr. Conn's aldosterone anymore.

Authors:  Nancy J Brown
Journal:  Trans Am Clin Climatol Assoc       Date:  2011

9.  Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha.

Authors:  C A Carvajal; A A Herrada; C R Castillo; F J Contreras; C B Stehr; L M Mosso; A M Kalergis; C E Fardella
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

10.  Differential aerobic exercise-induced changes in plasma aldosterone between African Americans and Caucasians.

Authors:  Jennifer M Jones; Thomas C Dowling; Jung-Jun Park; Dana A Phares; Joon-Young Park; Thomas O Obisesan; Michael D Brown
Journal:  Exp Physiol       Date:  2007-05-04       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.